Marzena Pazgier

6.6k total citations
103 papers, 3.9k citations indexed

About

Marzena Pazgier is a scholar working on Virology, Immunology and Molecular Biology. According to data from OpenAlex, Marzena Pazgier has authored 103 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Virology, 48 papers in Immunology and 37 papers in Molecular Biology. Recurrent topics in Marzena Pazgier's work include HIV Research and Treatment (49 papers), Monoclonal and Polyclonal Antibodies Research (30 papers) and Immune Cell Function and Interaction (30 papers). Marzena Pazgier is often cited by papers focused on HIV Research and Treatment (49 papers), Monoclonal and Polyclonal Antibodies Research (30 papers) and Immune Cell Function and Interaction (30 papers). Marzena Pazgier collaborates with scholars based in United States, Canada and China. Marzena Pazgier's co-authors include Wuyuan Lu, J. Łubkowski, Weiyue Lu, Weirong Yuan, David M. Hoover, Min Liu, De Yang, Changqing Li, Guozhang Zou and George K. Lewis and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Marzena Pazgier

97 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marzena Pazgier United States 34 2.1k 1.3k 1.2k 822 582 103 3.9k
W. Lee Maloy United States 28 2.5k 1.2× 2.5k 1.9× 1.4k 1.1× 131 0.2× 350 0.6× 39 4.0k
Thomas J. Ketas United States 33 1.3k 0.6× 313 0.2× 1.4k 1.1× 2.9k 3.5× 208 0.4× 45 4.0k
Istvan Botos United States 27 1.8k 0.9× 348 0.3× 1.3k 1.1× 170 0.2× 241 0.4× 48 3.4k
Timothy A. Mietzner United States 35 1.4k 0.7× 1.1k 0.8× 425 0.4× 302 0.4× 137 0.2× 68 3.2k
Yechiel Shai Israel 29 2.5k 1.2× 2.3k 1.7× 1.0k 0.8× 167 0.2× 322 0.6× 55 3.7k
David M. Hoover United States 19 1.9k 0.9× 1.9k 1.4× 1.2k 1.0× 74 0.1× 415 0.7× 25 3.5k
Ana Salomé Veiga Portugal 25 1.6k 0.8× 1.1k 0.8× 259 0.2× 207 0.3× 311 0.5× 59 2.4k
Qinxue Hu China 34 984 0.5× 279 0.2× 1.0k 0.9× 1.1k 1.4× 88 0.2× 101 3.5k
Gerard C.F. van Duijnhoven Netherlands 9 1.2k 0.6× 194 0.1× 3.1k 2.6× 1.5k 1.8× 201 0.3× 10 4.4k
David Schibli Canada 14 1.4k 0.6× 1.0k 0.8× 424 0.4× 278 0.3× 148 0.3× 21 1.9k

Countries citing papers authored by Marzena Pazgier

Since Specialization
Citations

This map shows the geographic impact of Marzena Pazgier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marzena Pazgier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marzena Pazgier more than expected).

Fields of papers citing papers by Marzena Pazgier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marzena Pazgier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marzena Pazgier. The network helps show where Marzena Pazgier may publish in the future.

Co-authorship network of co-authors of Marzena Pazgier

This figure shows the co-authorship network connecting the top 25 collaborators of Marzena Pazgier. A scholar is included among the top collaborators of Marzena Pazgier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marzena Pazgier. Marzena Pazgier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tauzin, Alexandra, Mehdi Benlarbi, Ling Niu, et al.. (2025). Impact of Vaccine-Elicited Anti-Spike IgG4 Antibodies on Fc-Effector Functions Against SARS-CoV-2. Viruses. 17(5). 666–666.
2.
Liao, Chongbing, Jin Yan, William D. Tolbert, et al.. (2025). A Dual-Specificity d-Peptide Antagonist of MDM2 and MDMX for Antitumor Immunotherapy. Journal of Medicinal Chemistry. 68(16). 16940–16957.
3.
Grunst, Michael W., Zhuan Qin, Shilei Ding, et al.. (2024). Structure and inhibition of SARS-CoV-2 spike refolding in membranes. Science. 385(6710). 757–765. 20 indexed citations
4.
Gong, Shang Yu, Shilei Ding, Mehdi Benlarbi, et al.. (2022). Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2. Viruses. 14(10). 2178–2178. 9 indexed citations
5.
Kuwata, Takeo, William D. Tolbert, Jonathan Richard, et al.. (2022). Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates. Journal of Virology. 97(1). e0163822–e0163822. 4 indexed citations
6.
Ding, Shilei, Dani Vézina, Jean-Philippe Chapleau, et al.. (2019). Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity. ACS Medicinal Chemistry Letters. 11(3). 371–378. 10 indexed citations
7.
Tolbert, William D., Ganesh P. Subedi, Neelakshi Gohain, et al.. (2019). From Rhesus macaque to human: structural evolutionary pathways for immunoglobulin G subclasses. mAbs. 11(4). 709–724. 15 indexed citations
8.
Xu, Dan, Chongbing Liao, Bing Zhang, et al.. (2018). Human Enteric α-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion. Immunity. 48(6). 1233–1244.e6. 43 indexed citations
9.
Li, Xiang, William D. Tolbert, Honggang Hu, et al.. (2018). Dithiocarbamate-inspired side chain stapling chemistry for peptide drug design. Chemical Science. 10(5). 1522–1530. 59 indexed citations
10.
Lewis, George K., Marzena Pazgier, David T. Evans, et al.. (2017). Beyond Viral Neutralization. AIDS Research and Human Retroviruses. 33(8). 760–764. 31 indexed citations
11.
Latinovic, Olga, Sandra Medina-Moreno, Neelakshi Gohain, et al.. (2015). Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies. AIDS Research and Human Retroviruses. 32(2). 178–186. 3 indexed citations
12.
Veillette, Maxime, Jonathan Richard, Marzena Pazgier, et al.. (2015). Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses. Current HIV Research. 14(1). 9–23. 37 indexed citations
13.
Lewis, George K., Yongjun Guan, Roberta Kamin‐Lewis, et al.. (2014). Epitope target structures of Fc-mediated effector function during HIV-1 acquisition. Current Opinion in HIV and AIDS. 9(3). 263–270. 27 indexed citations
14.
Chu, Hiutung, Marzena Pazgier, Grace Jung, et al.. (2012). Human α-Defensin 6 Promotes Mucosal Innate Immunity Through Self-Assembled Peptide Nanonets. Science. 337(6093). 477–481. 328 indexed citations
15.
Li, Chong, Marzena Pazgier, Changqing Li, et al.. (2010). Systematic Mutational Analysis of Peptide Inhibition of the p53–MDM2/MDMX Interactions. Journal of Molecular Biology. 398(2). 200–213. 120 indexed citations
16.
Wei, Gang, Erik de Leeuw, Marzena Pazgier, et al.. (2009). Through the Looking Glass, Mechanistic Insights from Enantiomeric Human Defensins. Journal of Biological Chemistry. 284(42). 29180–29192. 94 indexed citations
17.
Rajabi, Mohsen, Erik de Leeuw, Marzena Pazgier, et al.. (2008). The Conserved Salt Bridge in Human α-Defensin 5 Is Required for Its Precursor Processing and Proteolytic Stability. Journal of Biological Chemistry. 283(31). 21509–21518. 50 indexed citations
18.
Zou, Guozhang, Erik de Leeuw, Chong Li, et al.. (2007). Toward Understanding the Cationicity of Defensins. Journal of Biological Chemistry. 282(27). 19653–19665. 117 indexed citations
19.
Pazgier, Marzena, Xiangqun Li, Wuyuan Lu, & J. Łubkowski. (2007). Human Defensins: Synthesis and Structural Properties. Current Pharmaceutical Design. 13(30). 3096–3118. 56 indexed citations
20.
Turkiewicz, Marianna, Marzena Pazgier, Stuart P. Donachie, & Halina Kalinowska. (2005). Invertase and alpha-glucosidase production by the endemic Antarctic marine yeast Leucosporidium antarcticum. Polish Polar Research. 26(2). 125–136. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Lee Maloy Breakdown of academic impact, for papers by Thomas J. Ketas Breakdown of academic impact, for papers by Istvan Botos Breakdown of academic impact, for papers by Timothy A. Mietzner Breakdown of academic impact, for papers by Yechiel Shai Breakdown of academic impact, for papers by David M. Hoover Breakdown of academic impact, for papers by Ana Salomé Veiga Breakdown of academic impact, for papers by Qinxue Hu Breakdown of academic impact, for papers by Gerard C.F. van Duijnhoven Breakdown of academic impact, for papers by David Schibli
Rankless by CCL
2026